亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma

医学 放化疗 队列 内科学 放射治疗 肿瘤科 外科
作者
Nancy Y. Lee,Eric J. Sherman,Heiko Schöder,Rick Wray,Jay O. Boyle,Bhuvanesh Singh,Milan Grkovski,Ramesh Paudyal,Louise Cunningham,Zhigang Zhang,Vaios Hatzoglou,Nora Katabi,Bill H. Diplas,James E. Han,Brandon S. Imber,Khoi Pham,Yao Yu,Kaveh Zakeri,Sean M. McBride,Jung Julie Kang
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:42 (8): 940-950 被引量:64
标识
DOI:10.1200/jco.23.01308
摘要

PURPOSE Standard curative-intent chemoradiotherapy for human papillomavirus (HPV)–related oropharyngeal carcinoma results in significant toxicity. Since hypoxic tumors are radioresistant, we posited that the aerobic state of a tumor could identify patients eligible for de-escalation of chemoradiotherapy while maintaining treatment efficacy. METHODS We enrolled patients with HPV-related oropharyngeal carcinoma to receive de-escalated definitive chemoradiotherapy in a phase II study (ClinicalTrials.gov identifier: NCT03323463 ). Patients first underwent surgical removal of disease at their primary site, but not of gross disease in the neck. A baseline 18 F-fluoromisonidazole positron emission tomography scan was used to measure tumor hypoxia and was repeated 1-2 weeks intratreatment. Patients with nonhypoxic tumors received 30 Gy (3 weeks) with chemotherapy, whereas those with hypoxic tumors received standard chemoradiotherapy to 70 Gy (7 weeks). The primary objective was achieving a 2-year locoregional control (LRC) of 95% with a 7% noninferiority margin. RESULTS One hundred fifty-eight patients with T0-2/N1-N2c were enrolled, of which 152 patients were eligible for analyses. Of these, 128 patients met criteria for 30 Gy and 24 patients received 70 Gy. The 2-year LRC was 94.7% (95% CI, 89.8 to 97.7), meeting our primary objective. With a median follow-up time of 38.3 (range, 22.1-58.4) months, the 2-year progression-free survival (PFS) and overall survival (OS) rates were 94% and 100%, respectively, for the 30-Gy cohort. The 70-Gy cohort had similar 2-year PFS and OS rates at 96% and 96%, respectively. Acute grade 3-4 adverse events were more common in 70 Gy versus 30 Gy (58.3% v 32%; P = .02). Late grade 3-4 adverse events only occurred in the 70-Gy cohort, in which 4.5% complained of late dysphagia. CONCLUSION Tumor hypoxia is a promising approach to direct dosing of curative-intent chemoradiotherapy for HPV-related carcinomas with preserved efficacy and substantially reduced toxicity that requires further investigation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
量子星尘发布了新的文献求助10
2秒前
2秒前
6秒前
16秒前
lijiawei发布了新的文献求助10
18秒前
Criminology34发布了新的文献求助50
20秒前
睡觉补充能量完成签到,获得积分10
20秒前
fengfenghao完成签到,获得积分10
26秒前
小凯完成签到 ,获得积分10
29秒前
jueshadi完成签到 ,获得积分10
29秒前
朵朵完成签到,获得积分10
31秒前
36秒前
40秒前
dong发布了新的文献求助10
41秒前
43秒前
43秒前
43秒前
aaaaal发布了新的文献求助10
45秒前
47秒前
annaanna完成签到 ,获得积分10
49秒前
Criminology34发布了新的文献求助50
51秒前
ccc完成签到 ,获得积分10
51秒前
53秒前
YY发布了新的文献求助10
53秒前
Gin发布了新的文献求助10
56秒前
aaaaal完成签到,获得积分10
56秒前
Becky完成签到 ,获得积分10
59秒前
1分钟前
杨北风完成签到 ,获得积分20
1分钟前
科研通AI6应助科研通管家采纳,获得10
1分钟前
1分钟前
共享精神应助科研通管家采纳,获得10
1分钟前
1分钟前
所所应助科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
Hello应助科研通管家采纳,获得10
1分钟前
小蘑菇应助科研通管家采纳,获得10
1分钟前
1分钟前
ye发布了新的文献求助20
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Architectural Corrosion and Critical Infrastructure 1000
Early Devonian echinoderms from Victoria (Rhombifera, Blastoidea and Ophiocistioidea) 1000
By R. Scott Kretchmar - Practical Philosophy of Sport and Physical Activity - 2nd (second) Edition: 2nd (second) Edition 666
Electrochemistry: Volume 17 600
Physical Chemistry: How Chemistry Works 500
SOLUTIONS Adhesive restoration techniques restorative and integrated surgical procedures 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4944655
求助须知:如何正确求助?哪些是违规求助? 4209521
关于积分的说明 13085355
捐赠科研通 3989302
什么是DOI,文献DOI怎么找? 2184055
邀请新用户注册赠送积分活动 1199418
关于科研通互助平台的介绍 1112457